Literature DB >> 7332742

Spuriously high values of unbound drug fraction in serum as determined by the new ultrafree anticonvulsant drug filters.

M Ruprah, E Perucca, A Richens.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7332742      PMCID: PMC1401949          DOI: 10.1111/j.1365-2125.1981.tb01302.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors:  P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

2.  Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.

Authors:  J MacGee
Journal:  Anal Chem       Date:  1970-03       Impact factor: 6.986

3.  Albumin standards and the measurement of serum albumin with bromcresol green.

Authors:  B T Doumas; W A Watson; H G Biggs
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

4.  Gas-chromatographic assay of free phenytoin in ultrafiltrates of plasma: test of a new filtration apparatus and specimen stability.

Authors:  W A Joern
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

5.  Protein binding of several drugs in serum and plasma of healthy subjects.

Authors:  U W Wiegand; K L Hintze; J T Slattery; G Levy
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

  5 in total
  3 in total

Review 1.  Protein binding displacement interactions and their clinical importance.

Authors:  J C McElnay; P F D'Arcy
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

2.  Epileptic patients refractory to drug therapy.

Authors:  L Paris; M Giardina; R Pacifici; S Pichini; P Zuccaro; G Sideri
Journal:  Ital J Neurol Sci       Date:  1991-10

Review 3.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.